Events
A researcher specialising in the social and cultural factors that shape health and medicine has been announced as a speaker at a medical cannabis conference in London next month.
Cannabis explained
Sarah Sinclair ·
Events
News Editor ·
Events
Jodie Yettram ·
Journalism built on science, not speculation.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
A former Frankfurt drugs official will examine how stigma around cannabis can affect patients receiving it as a medical treatment at a conference in the city next month.
The association between cannabis and psychosis is among the most studied — and most contested — areas of cannabinoid medicine.
Whether cannabinoid medicines could offer a better overall treatment option than opioids for some people with chronic pain will be examined at a medical cannabis conference in Frankfurt this November.
Science & Evidence — Spotlight
We read the studies so you don’t have to — separating robust findings from headlines, with the methods and caveats laid bare.
Explore the research
Plain-language guides to conditions, cannabinoids and what the evidence actually says.
Explore patient guidesRegulatory change, clinical evidence and the patient perspective for prescribers and pharmacists.
Enter the clinical hubWhy clinicians attend the symposiumDirectory
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
